“Volume in Numbers…
Power from Volume”
Find Out MoreOur sites and Social Media platforms act as a podium for your company to talk to their audience – consumers.
We provide many portals for companies to host fully loaded comprehensive profiles, animated banner ads describing your company and its products in their true light, Videos, Business Plans, Executive Summaries, and PowerPoints. All of these features are provided free to the end user with no fees making it easy for your company to communicate and share resources with potential and active clients and consumers.
Planning, making strategies…
After successfull campaign…
Case Studies
Client Testimonials
News
- Factorial Energy Q2 Earnings Call Highlights
- Green Leaf Innovations, Inc. Signs Letter of Intent to Acquire 25% Equity Interest in DURTEQ(TM)
- 1606 Corp. Engages MDM Group to Market 55 MW AI Infrastructure Site in East Texas
- Wearable Devices Receives U.S. Patent Grant for Biometric User Authentication in Gesture and Voice-Controlled Interface Device
- 1606 Corp. Engages MDM Group to Market Lufkin 55 MW Powered Site to AI Infrastructure Operators and Strategic Buyers
- AXIL Brands Schedules Fiscal Fourth Quarter and Full Year 2026 Earnings Release and Conference Call for August 18
- 1606 Corp. Engages MDM Group to Market Lufkin 55 MW Powered Site to AI Infrastructure Operators and Strategic Buyers
- Circle8 Ranked #1 in 2025 Dutch Public-Sector Broker/MSP Contract Awards, With Approximately US$2.39 Billion in Awarded Framework Value
- ZenaTech’s ZenaDrone Begins In-House PCB Flight Testing, Advancing Vertical Integration Strategy Toward NDAA-Compliant Blue UAS Certification and Expanded Defense Opportunities
- SPP Credit Advisors and Circle8 Group Eliminate $35 Million Convertible Seller's Note in Global Settlement Agreement
- NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles
- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
- Cycurion Confirms August 20 Nasdaq Hearing Date; Common Stock Continues Trading on Nasdaq
- FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
- Alarm.com Holdings (ALRM) Q2 Earnings and Revenues Top Estimates
